HEPATITIS C, CHRONIC
Clinical trials for HEPATITIS C, CHRONIC explained in plain language.
Never miss a new study
Get alerted when new HEPATITIS C, CHRONIC trials appear
Sign up with your email to follow new studies for HEPATITIS C, CHRONIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill combo shows promise against hepatitis c in Mid-Stage trial
Disease control CompletedThis study tested a combination of two oral drugs, bemnifosbuvir and ruzasvir, in 275 adults with chronic hepatitis C. The main goal was to see if the treatment could clear the virus from the blood 12 weeks after finishing therapy. The trial was open-label, meaning everyone knew …
Matched conditions: HEPATITIS C, CHRONIC
Phase: PHASE2 • Sponsor: Atea Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 17, 2026 04:29 UTC
-
New hope for HIV patients with stubborn hepatitis c
Disease control CompletedThis study tested a combination of two drugs, peginterferon alfa-2a and ribavirin, as a second-line treatment for chronic hepatitis C in 17 people with HIV who did not respond to their first hepatitis C treatment. The goal was to see if this 48-week treatment could make the hepat…
Matched conditions: HEPATITIS C, CHRONIC
Phase: PHASE2 • Sponsor: University Hospital, Bordeaux • Aim: Disease control
Last updated May 17, 2026 04:25 UTC
-
Bringing hep c care to addiction clinics boosts treatment success
Disease control CompletedThis study tested whether treating hepatitis C virus (HCV) inside clinics that already provide opioid addiction therapy works better than sending patients to separate infectious disease clinics. About 298 people on opioid therapy took part. The goal was to see if integrated care …
Matched conditions: HEPATITIS C, CHRONIC
Phase: NA • Sponsor: Haukeland University Hospital • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
New hope: hepatitis c drugs after liver cancer
Disease control CompletedThis study looked at 150 people with both hepatitis C and a history of liver cancer that was successfully treated. They received new, interferon-free drugs to cure the hepatitis C virus. The main goal was to see if the virus stays gone 12 weeks after treatment, and also to check …
Matched conditions: HEPATITIS C, CHRONIC
Phase: PHASE3 • Sponsor: National Hepatology & Tropical Medicine Research Institute • Aim: Disease control
Last updated May 11, 2026 20:47 UTC
-
Can a heart pill protect the liver? new study tests irbesartan against hepatitis c scarring
Disease control CompletedThis study tested whether irbesartan, a blood pressure medication, can slow the progression of liver fibrosis (scarring) in adults with chronic hepatitis C who cannot take or did not respond to antiviral therapy. 166 participants took either irbesartan or a placebo daily for two …
Matched conditions: HEPATITIS C, CHRONIC
Phase: PHASE3 • Sponsor: ANRS, Emerging Infectious Diseases • Aim: Disease control
Last updated May 06, 2026 16:01 UTC
-
New hope for HIV patients with stubborn hepatitis c
Disease control CompletedThis study tested a 12-week course of telaprevir added to a longer course of peginterferon and ribavirin in 70 adults with both HIV and hepatitis C who had not been helped by earlier treatment. The goal was to see if this combination could clear the hepatitis C virus for good. Th…
Matched conditions: HEPATITIS C, CHRONIC
Phase: PHASE2 • Sponsor: ANRS, Emerging Infectious Diseases • Aim: Disease control
Last updated May 05, 2026 11:54 UTC